Quinazolinones, a prominent scaffold in medicinal chemistry,
exhibits a wide array of biological activities. This research focused on
synthesizing and evaluating two series of 3-substituted quinazolin-4(3H)-ones
for their antioxidant properties. The evaluation encompassed both in vitro
methods, namely DPPH and reducing power method, and in vivo studies using lipid
peroxidation, superoxide dismutase (SOD), catalase, glutathione reductase, and
glutathione peroxidase assays on erythrocytes of carbon tetrachloride-intoxicated
rats. The objective was to establish structure-antioxidant activity
relationships based on diverse substituents at position 3 of the quinazolinone
scaffold. The newly synthesized quinazoline derivatives, designated as 7a1-7a8
and 7b1-7b8, displayed notable antioxidant properties, potentially contributing
to their observed biological activity. Among the two series, compound 7b5,
bearing a methyl piperazine at the 3rd position and a chlorine atom at the 6th
position on the 3-substituted quinazoline nucleus, exhibited outstanding
antioxidant activity in both in vitro and in vivo methods. Furthermore,
compounds 7a5 and 7a8 demonstrated significant antioxidant properties in the
DPPH assay, while compounds 7a3, 7a4, 7a5, and 7a8 displayed notable activity
in the reducing power method. In vivo
studies revealed significant antioxidant properties in compounds 7a5, 7a8, 7b4,
7b6, and 7b8. Additionally, compounds 7a6 and 7b7 showed promising antioxidant
activity in vivo. These findings underscore the potential of quinazoline-based
compounds as therapeutic agents for managing oxidative stress-related
disorders.
Author
(s) Details
Praveen Kumar Kusuma
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences,
Delhi Pharmaceutical Sciences and Research University, New Delhi-110017, India.
Girijasastry Vedula
Department of Pharmaceutical Sciences, College of Pharmacy, Andhra
University, Visakhapatnam – 530003, India.
Please see the book here:- https://doi.org/10.9734/bpi/rdcbr/v7/2769
No comments:
Post a Comment